Summary of cost-utility compatible studies. Author Source of Hypothetical Valuation Country Indication Interventions Population (year) process utility health states methodology Birch USA Cervical Medical Watchful wait 6 scenarios: 3 for Patients Two stage SG (2003) screening management (conservative) conservative (women) Upper anchor: full of mildly vs. aggressive management and health abnormal Pap management 3 for aggressive Lower anchor: smears cancer requiring hysterectomy Boye Scotland T2DM Injectable Flexible dosing, 9 scenarios: 1 Patients Two stage SG (2011) treatment treatments number of basic health state, Upper anchor: injections and 8 using basic perfect health health state plus Lower anchor: worst statements health represented describing by a person with injectable T2DM, blood
Summary of cost-utility compatible studies. Author (year) Country Indication Interventions Source of process utility Hypothetical health states Population Valuation methodology Birch (2003) USA Cervical screening Medical management of mildly abnormal Pap smears Watchful wait (conservative) vs. aggressive management 6 scenarios: 3 for conservative management and 3 for aggressive Patients (women) Two stage SG Upper anchor: full health Lower anchor: cancer requiring hysterectomy Boye (2011) Scotland T2DM treatment Injectable treatments Flexible dosing, number of injections 9 scenarios: 1 basic health state, and 8 using basic health state plus statements describing injectable Patients Two stage SG Upper anchor: perfect health Lower anchor: worst health represented by a person with T2DM, blood